"Designing Growth Strategies is in our DNA"

Hyperphosphatemia Treatment Market Size, Share & COVID-19 Impact Analysis, By Product (Sevelamer, Calcium-based Phosphate Binders, Iron-based Phosphate Binders, Lanthanum Carbonate, Others and Non-phosphate Binders); By Distribution Channel (Hospital Pharmacy, Retail Pharmacies, and Online Pharmacies) and Regional Forecasts, 2021-2028

Region : Global | Format: PDF | Report ID: FBI100325

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Hyperphosphatemia, By Key Countries/ Regions, 2020
    2. Pipeline Analysis, By Key Players
    3. New Product Launches, by Key Players
    4. Key Industry Developments- Partnerships, Mergers, and Acquisitions
    5. Global Revenues Generated by Major Branded Drugs in Every Drug Class Category such as Renagel, RenVela, Fosrenol, Velphoro, and Auryxia(2020)
    6. Impact of COVID-19 on the Market
  5. Global Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Hyperphosphatemia Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Sevelamer
      2. Calcium-based Phosphate Binders
      3. Iron-based Phosphate Binders
      4. Lanthanum Carbonate
      5. Others
      6. Non-phosphate Binders
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
      1. Sanofi
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      2. Takeda Pharmaceutical Company Limited
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      3. Astellas Pharma Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      4. Akebia Therapeutics, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      5. Vifor Pharma Management Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      6. Lupin Limited
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      7. Ardelyx, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      8. Unicycive Therapeutics Inc
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      9. Other Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
Read Less

Figure 01: Global Hyperphosphatemia Treatment Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 02: Global Hyperphosphatemia Treatment Market Value Share (%), by Product, 2020 & 2028

Figure 03: Global Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 04: Global Hyperphosphatemia Treatment Market Value (USD billion), by Region, 2020 & 2028

Figure 05: North America Hyperphosphatemia Treatment Market Value (USD billion), by Product, 2020 & 2028

Figure 06: North America Hyperphosphatemia Treatment Market Value Share (%), by Product, 2020

Figure 07: North America Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 08: North America Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 09: North America Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 10: North America Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2020

Figure 11: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Product, 2020 & 2028

Figure 12: Europe Hyperphosphatemia Treatment Market Value Share (%), by Product, 2020

Figure 13: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 14: Europe Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 15: Europe Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 16: Europe Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2020

Figure 17: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Product, 2020 & 2028

Figure 18: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Product, 2020

Figure 19: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 20: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 21: Asia Pacific Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 22: Asia Pacific Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2020

Figure 23: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by product, 2020 & 2028

Figure 24: Latin America Hyperphosphatemia Treatment Market Value Share (%), by product, 2020

Figure 25: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 26: Latin America Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 27: Latin America Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 28: Latin America Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2020

Figure 29: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by product, 2020 & 2028

Figure 30: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by product, 2020

Figure 31: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 32: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 33: Middle East and Africa Hyperphosphatemia Treatment Market Value (USD billion), by Country/Sub-region, 2020 & 2028

Figure 34: Middle East and Africa Hyperphosphatemia Treatment Market Value Share (%), by Country/Sub-region, 2020

Figure 35: Global Hyperphosphatemia Treatment Market Share Analysis (%), By Company, 2020

Table 01: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Product, 2017-2028

Table 02: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 03: Global Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 04: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Product, 2017-2028

Table 05: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 06: North America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2017-2028

Table 07: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Product, 2017-2028

Table 08: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 09: Europe Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2017-2028

Table 10: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Product, 2017-2028

Table 11: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 12: Asia Pacific Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2017-2028

Table 13: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by product, 2017-2028

Table 14: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 15: Latin America Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2017-2028

Table 16: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by product, 2017-2028

Table 17: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 18: Middle East and Africa Hyperphosphatemia Treatment Market Revenue (USD billion) Forecast, by Country / Sub-region, 2017-2028

Booklet
  • Aug, 2021
  • 2020
  • 2017-2019
  • 115

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X